$THC

Tenet Healthcare Corporation (THC) Stock Forecasts

Argus raised its target price for Tenet Healthcare (THC) to $294.00. The company operates 47 hospitals and over 500 outpatient facilities in the US, mainly in the South. This update may impact investor sentiment and trading activity for THC.

Original reporting
Published Oct 14, 2026, 11:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 3:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$THC
Bullish
high confidence
Mentioned
$THC · $DVA · $UNM · $WAT · $MOH
Relevance
5/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$THCBullishMed
01

Why it matters

Target revisions provide fresh guidance that can influence short-term price movements.

02

Market read

Analyst target updates can prompt short-term trading activity across the listed stocks.

03

What to watch

Broader market sentiment could mute impact of individual target updates.

Relevance 5/10Novelty 6/10Timing: same-day release

Background

The article lists recent analyst target price adjustments for several U.S.-listed companies.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Analyst raised Tenet Healthcare target price to $294.00.

Expected impact

likely upward pressure as investors price in higher target.

Evidence & confidence

Target raise is a fresh analyst opinion, indicating improved expectations.

$DVABullishHigh confidence
Context

Analyst raised DVA target price to $191.00.

Expected impact

potential upward pressure.

Evidence & confidence

Fresh analyst upgrade.

$UNMBullishHigh confidence
Context

Analyst raised UNM target price to $97.00.

Expected impact

likely upward pressure.

Evidence & confidence

New target price is primary information.

$WATBearishHigh confidence
Context

Analyst lowered WAT target price to $472.00.

Expected impact

likely downward pressure.

Evidence & confidence

Fresh analyst downgrade.

$MOHBullishHigh confidence
Context

Analyst raised MOH target price to $220.00.

Expected impact

potential upside.

Evidence & confidence

New target price provides fresh guidance.

Market effects

Healthcare and related sectors may see modest revaluation.

U.S. equities may experience slight upward bias from multiple target raises.

Limited to U.S. listed stocks.

Counterpoint

Target changes may be premature; wait for earnings confirmation.

Key entities

  • Tenet Healthcare Corporation

    Healthcare services provider.

  • CI

    Company with ticker CI.

  • DVA

    Company with ticker DVA.

  • UNM

    Company with ticker UNM.

  • WAT

    Company with ticker WAT.

Related articles

$MOHMed

Molina Healthcare Inc (MOH) (Q3 2026) Earnings Call Highlights: Reaffirmed Guidance

Molina Healthcare (MOH) reported Q3 2026 adjusted pre-tax margin of 0.6% and reaffirmed guidance. Medicaid cost trend rose to 5.5%, and new contracts in Georgia/Texas were delayed. Marketplace and Medicare MAPD segments are expected to lose $0.75 and $1 per share, respectively, in 2026. CEO Joe Zubretsky and CFO Mark Keim discussed Medicaid MLR improvements, Florida CMS contract, and enrollment declines.

$MOHHighAI 8/10

Molina Healthcare Q3 Earnings Call Highlights

Molina Healthcare (MOH) expects its legacy Medicaid business to achieve a 1.6% pretax margin in 2026, with a 6% rate increase projected for 2027. The company anticipates a 6% membership decline in 2027 due to federal work requirements. Its Florida CMS contract, started in Q3, is expected to create a $1.50-per-share earnings drag in 2026. Molina's 2027 premium revenue is projected at $45 billion, down from $46.5 billion. The company's Medicare and Marketplace segments show mixed performance.

$MOHHighAI 8/10

Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript

Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89B on $10.5B premium revenue, with a 92.9% MCR. Full-year 2026 guidance remains $42B in premium revenue and at least $5.25 EPS. 2027 premium revenue is expected to be at least $45B, with known rate increases averaging 6% and medical cost trend projected at 5.5%-6%. The company reaffirmed its Medicaid and Medicare strategies, including exiting the MAPD business and reducing Marketplace footprint.

$MOHHighAI 8/10

Molina: Q3 Earnings Snapshot

Molina Healthcare (MOH) reported Q3 net income of $38M, or 73 cents per share, beating analyst estimates of 72 cents. Revenue was $11.08B, exceeding expectations of $10.93B. The company forecasts full-year earnings of $5.25 per share and revenue of $42B.